Congratulation to the team of Dr Antoinette Perry, Asia Jordan, Adele Connor and Ross Nelson for their success in the midst of very steep competition in winning the UCD VentureLaunch Accelerator Programme Award for epiCaPture. Antoinette and her team have developed a novel urine DNA test for aggressive prostate cancer. Its tumor specificity out-performs that of prostate-specific antigen (greater than 3 ng/mL). Used as an adjunct to prostate-specific antigen, epiCaPture could aid patient stratification to determine need for biopsy.
https://pubmed.ncbi.nlm.nih.gov/30801051/
